India got it earlier this year, and Canada approved it last month. But when is the United States going to get a generic version of Ozempic? Not this decade, experts say. Thanks largely to loopholes in the U.S. patent system, Americans aren’t expected to get generic forms of semaglutide , the drug in Novo Nordisk’s Ozempic and Wegovy, until at least the end of 2031. Even that timing is uncertain, said Arti K. Rai, a professor at the Duke University School of Law and former senior official in the